Description

The Infant Bilirubin Phototherapy Unit YG0239 is a state-of-the-art mobile device designed to effectively treat neonatal jaundice through phototherapy. This unit uses five blue fluorescent tubes, which emit light within a wavelength range of 400-550nm, ideal for the breakdown of bilirubin in the skin. The device is equipped with an LED digital timer that displays both the therapy time and the total time, ensuring that the treatment process is properly monitored and controlled. Its compact and mobile design makes it easy to move between different areas of a neonatal care unit.

Market Price

The Infant Bilirubin Phototherapy Unit YG0239 is available on the market at a competitive price, typically ranging between $718 and $730, depending on the supplier and the specific features included in the package. Given its efficiency, durable light source, and the added benefit of a mobile design, this device provides excellent value for hospitals and clinics needing a reliable and cost-effective solution for neonatal jaundice treatment.

Frequently Asked Questions

• What is the ideal distance for effective treatment with this unit? The treatment distance for the YG0239 varies between 10px and 500px. The adjustable height feature allows you to maintain the optimal distance from the baby’s skin for maximum phototherapy efficacy.
• How long can the light source last before needing a replacement? The light source of the Infant Bilirubin Phototherapy Unit YG0239 is designed to last for up to 1000 hours, ensuring long-lasting performance before needing any maintenance or bulb replacement.
• Is the device noisy? No, the YG0239 operates at a noise level of ≤55dB(A), which is quite low and suitable for use in neonatal care environments where minimizing noise is crucial.

Advantages and Disadvantages

Advantages:

• Effective phototherapy with a wide treatment area (1125px x 600px).
• Energy-efficient with an input power of <150VA.
• Adjustable height and angles for customizable treatment.
• Low noise level suitable for sensitive environments like NICUs.
• Long-lasting light source, requiring minimal maintenance.

Disadvantages:

• The device’s effective treatment distance may need to be closely monitored, as it varies based on the baby’s position.
• The light source’s lifetime of 1000 hours may require replacement after extended use.

Field Use

In a clinical setting, the Infant Bilirubin Phototherapy Unit YG0239 is primarily used for treating neonatal jaundice in newborns. The device’s adjustable features allow healthcare providers to tailor the therapy to the infant’s specific needs, ensuring efficient treatment while minimizing discomfort. The blue light tubes emit the necessary wavelengths to break down excess bilirubin in the baby’s blood, helping to reduce jaundice symptoms and prevent further complications.

Recommendations

To ensure optimal performance and longevity of the YG0239 phototherapy unit, regular maintenance of the light source and digital timer is recommended. Additionally, ensure that the unit is positioned correctly to achieve the optimal treatment distance from the baby’s skin. This will maximize the effectiveness of the therapy and reduce the risk of complications.

Technical Specifications